Paracrine TGF-Beta Signaling in Tumor Initiation and Progression
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression
批准号:
7496880
负责人:
LYNN M MATRISIAN
金额:
$7.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-25 至 2011-08-31
关键词:
AffectApoptosisAutomobile DrivingBehaviorBiologicalBiological AssayBiological ModelsCXCR4 geneCarcinomaCell LineCell modelCellsClassClinicalComputer SimulationDataDepthDevelopmentEnvironmentEpithelialEpithelial Cell ProliferationEpithelial CellsEpithelial-Stromal CommunicationEpitheliumFZD2 geneFeedbackFibroblastsGenotypeGrowthGrowth FactorHumanInvasiveLesionLigandsMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of prostateMeasuresMediatingMesenchymeMethodsMicrodialysisModelingModificationMolecularMusMutant Strains MiceNumbersOrganPTHLH geneParacrine CommunicationPathway interactionsPersonal SatisfactionPlayProcessProstateProstate carcinomaProstaticProstatic Intraepithelial NeoplasiasProstatic StromaProtein OverexpressionProteinsProteomicsPurposeRangeRegulationRelative (related person)RoleSamplingSeriesSignal PathwaySignal TransductionSignaling MoleculeStromal CellsTGFB1 geneTechniquesTestingTimeTissue RecombinationTransforming Growth Factor betaTransgenic MiceTransgenic OrganismsUrogenital SinusViral Vectorautocrinebasebonecarcinogenesischemokinecomputerized data processingconceptcostcytokinehuman FZD2 proteinin vivoinhibitor/antagonistlentiviral-mediatedmathematical modelmodels and simulationmouse modelneoplasticparacrineparathyroid hormone-related proteinreceptorreceptor expressionresearch studyresponsesmall moleculetumor initiationtumor progressiontumorigenesistumorigenic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This proposal seeks to establish the Vanderbilt University Tumor Microenvironment Network (VUTMEN) to
contribute to the generation of a comprehensive understanding of the role of the tumor stroma in cancer
initiation, progression, and metastasis. The strategy used by the VUTMEN is to focus our efforts on
understanding the downstream mechanisms used by a critical biological mediator of host:tumor
interactions.TGFbeta. Project 1 uses sophisticated mouse genetics and advanced proteomic technologies to
identify the downstream effectors of tumor and stromal TGF|3 signaling pathways that influence mammary
gland tumorigenesis. Project 2 uses a combination of human prostate cancer and mouse model-derived
cells and the tissue recombination model to examine the effectors of TGFp that modulate prostatic
carcinogenesis. The role of TGFbeta in driving the vicious cycle that regulates the growth of breast metastases
in bone is the topic of Project 3. All results will be followed up in human tumor samples. The VUTMEN
supports 3 "Integrative Shared Resources" that bring state-of-the-art technologies and a systems biology
approach to the three VUTMEN projects. The Protein Collection and Proteomics Core provides proteomic
technologies specifically relevant to the tumor microenvironment, including microdialysis and imaging mass
spectroscopy. The Image Fusion Core is devoted to novel imaging strategies that enhance the
understanding of the tumor microenvironment, including a multi-parametric and multi-modality approach
known as image fusion. The Biomathematics and Bioinformatics Core develops new approaches to
analyzing complex data sets and generates mathematical models for iterative hypothesis generation and
testing. We propose that the acknowledged complexity of the tumor microenvironment can be unraveled by
the strategy of focusing our efforts on the key regulatory pathway of TGFbeta. This will be achieved through the
systematic examination of known molecular modulators that are downstream of TGFbeta and the discovery of
new ones using proteomic approaches, examining biological effects in vivo in real time and correlating the
results with molecular parameters using genetic manipulation and image fusion technologies, using
mathematical modeling to iteratively generate hypotheses and test them experimentally, and comparing the
results in three distinct but related organ sites. Our goal is to generate a comprehensive understanding of
the mechanisms used by TGFbeta to control the reciprocal interactions between a tumor and its
microenvironment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Training
-
批准号:8340449
-
项目类别:
-
资助金额:$20.17万
-
财政年份:2011
-
负责人:LYNN M MATRISIAN
-
依托单位:
Histopathology Core
-
批准号:8340447
-
项目类别:
-
资助金额:$4.67万
-
财政年份:2011
-
负责人:LYNN M MATRISIAN
-
依托单位:
Cancer Outreach Core
-
批准号:8340442
-
项目类别:
-
资助金额:$15.61万
-
财政年份:2011
-
负责人:LYNN M MATRISIAN
-
依托单位:
Biostatistics Core
-
批准号:8340441
-
项目类别:
-
资助金额:$2.32万
-
财政年份:2011
-
负责人:LYNN M MATRISIAN
-
依托单位:
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression
-
批准号:8340131
-
项目类别:
-
资助金额:$7.39万
-
财政年份:2011
-
负责人:LYNN M MATRISIAN
-
依托单位:
A Multi-Center Epidemiologic Study of Breast Cancer in African-American Women
-
批准号:8340436
-
项目类别:
-
资助金额:$9.03万
-
财政年份:2011
-
负责人:LYNN M MATRISIAN
-
依托单位:
Planning and Evaluation Core
-
批准号:8340448
-
项目类别:
-
资助金额:$2.85万
-
财政年份:2011
-
负责人:LYNN M MATRISIAN
-
依托单位:
Administration Core
-
批准号:8340018
-
项目类别:
-
资助金额:$11.04万
-
财政年份:2011
-
负责人:LYNN M MATRISIAN
-
依托单位:
Host Microenvironment and Bone Metastases
-
批准号:7899992
-
项目类别:
-
资助金额:$35.01万
-
财政年份:2009
-
负责人:LYNN M MATRISIAN
-
依托单位:
Proteolytic Beacons in the Non-invasive Assessment of Response to Cancer Therapy
-
批准号:7490272
-
项目类别:
-
资助金额:$10.45万
-
财政年份:2008
-
负责人:LYNN M MATRISIAN
-
依托单位:
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression
-
批准号:7289826
-
项目类别:
-
资助金额:$149.21万
-
财政年份:2006
-
负责人:LYNN M MATRISIAN
-
依托单位:
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression
-
批准号:7479307
-
项目类别:
-
资助金额:$150.02万
-
财政年份:2006
-
负责人:LYNN M MATRISIAN
-
依托单位:
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression
-
批准号:7913503
-
项目类别:
-
资助金额:$5.26万
-
财政年份:2006
-
负责人:LYNN M MATRISIAN
-
依托单位:
Administrative Core
-
批准号:7243994
-
项目类别:
-
资助金额:$10.45万
-
财政年份:2006
-
负责人:LYNN M MATRISIAN
-
依托单位:
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression
-
批准号:7232518
-
项目类别:
-
资助金额:$155.0万
-
财政年份:2006
-
负责人:LYNN M MATRISIAN
-
依托单位:
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression
-
批准号:7899997
-
项目类别:
-
资助金额:$142.0万
-
财政年份:2006
-
负责人:LYNN M MATRISIAN
-
依托单位:
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression
-
批准号:7679654
-
项目类别:
-
资助金额:$208.99万
-
财政年份:2006
-
负责人:LYNN M MATRISIAN
-
依托单位:
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression
-
批准号:8127104
-
项目类别:
-
资助金额:$4.51万
-
财政年份:2006
-
负责人:LYNN M MATRISIAN
-
依托单位:
Training
-
批准号:6989653
-
项目类别:
-
资助金额:$13.03万
-
财政年份:2004
-
负责人:LYNN M MATRISIAN
-
依托单位:
Small Animal MRI with Protease-Sensing Contrast Agents
-
批准号:6952824
-
项目类别:
-
资助金额:$26.41万
-
财政年份:2004
-
负责人:LYNN M MATRISIAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: